207 related articles for article (PubMed ID: 33176870)
1. Effectiveness and tolerability of repetitive transcranial magnetic stimulation for preventive treatment of episodic migraine: a single-centre, randomised, double-blind, sham-controlled phase 2 trial (Magnet-EM).
Mohamad Safiai NI; Amir NA; Basri H; Inche Mat LN; Hoo FK; Yusof Khan AHK; Loh WC; Chia PK; Ramachandran V; Mat Din H; Samsudin IN; Fernandez A; Mohamed MH; Ching SM; Hashim HZ; Wan Sulaiman WA
Trials; 2020 Nov; 21(1):923. PubMed ID: 33176870
[TBL] [Abstract][Full Text] [Related]
2. Safety and efficacy of galcanezumab in patients for whom previous migraine preventive medication from two to four categories had failed (CONQUER): a multicentre, randomised, double-blind, placebo-controlled, phase 3b trial.
Mulleners WM; Kim BK; Láinez MJA; Lanteri-Minet M; Pozo-Rosich P; Wang S; Tockhorn-Heidenreich A; Aurora SK; Nichols RM; Yunes-Medina L; Detke HC
Lancet Neurol; 2020 Oct; 19(10):814-825. PubMed ID: 32949542
[TBL] [Abstract][Full Text] [Related]
3. Safety, tolerability, and efficacy of TEV-48125 for preventive treatment of high-frequency episodic migraine: a multicentre, randomised, double-blind, placebo-controlled, phase 2b study.
Bigal ME; Dodick DW; Rapoport AM; Silberstein SD; Ma Y; Yang R; Loupe PS; Burstein R; Newman LC; Lipton RB
Lancet Neurol; 2015 Nov; 14(11):1081-90. PubMed ID: 26432182
[TBL] [Abstract][Full Text] [Related]
4. Increased migraine-free intervals with multifocal repetitive transcranial magnetic stimulation.
Leahu P; Bange M; Ciolac D; Scheiter S; Matei A; Gonzalez-Escamilla G; Chirumamilla VC; Groppa SA; Muthuraman M; Groppa S
Brain Stimul; 2021; 14(6):1544-1552. PubMed ID: 34673259
[TBL] [Abstract][Full Text] [Related]
5. High-frequency repetitive transcranial magnetic stimulation at dorsolateral prefrontal cortex for migraine prevention: A protocol for a systematic review of controlled trials.
Mohamad Safiai NI; Mohamad NA; Basri H; Inche Mat LN; Hoo FK; Abdul Rashid AM; Yusof Khan AHK; Loh WC; Baharin J; Fernandez A; Samsudin IN; Mohamed MH; Siew MC; Lee KW; Ramachandran V; Pozo-Rosich P; Wan Sulaiman WA
PLoS One; 2021; 16(6):e0251528. PubMed ID: 34138860
[TBL] [Abstract][Full Text] [Related]
6. Efficacy of intermittent Theta Burst Stimulation (iTBS) and 10-Hz high-frequency repetitive transcranial magnetic stimulation (rTMS) in treatment-resistant unipolar depression: study protocol for a randomised controlled trial.
Bulteau S; Sébille V; Fayet G; Thomas-Ollivier V; Deschamps T; Bonnin-Rivalland A; Laforgue E; Pichot A; Valrivière P; Auffray-Calvier E; Fortin J; Péréon Y; Vanelle JM; Sauvaget A
Trials; 2017 Jan; 18(1):17. PubMed ID: 28086851
[TBL] [Abstract][Full Text] [Related]
7. Randomised controlled feasibility trial of real versus sham repetitive transcranial magnetic stimulation treatment in adults with severe and enduring anorexia nervosa: the TIARA study.
Dalton B; Bartholdy S; McClelland J; Kekic M; Rennalls SJ; Werthmann J; Carter B; O'Daly OG; Campbell IC; David AS; Glennon D; Kern N; Schmidt U
BMJ Open; 2018 Jul; 8(7):e021531. PubMed ID: 30012789
[TBL] [Abstract][Full Text] [Related]
8. Efficacy and safety of exogenous ketone bodies for preventive treatment of migraine: A study protocol for a single-centred, randomised, placebo-controlled, double-blind crossover trial.
Gross E; Putananickal N; Orsini AL; Schmidt S; Vogt DR; Cichon S; Sandor P; Fischer D
Trials; 2019 Jan; 20(1):61. PubMed ID: 30654835
[TBL] [Abstract][Full Text] [Related]
9. Randomized, proof-of-principle clinical trial of active transcranial magnetic stimulation in chronic migraine.
Conforto AB; Amaro E; Gonçalves AL; Mercante JP; Guendler VZ; Ferreira JR; Kirschner CC; Peres MF
Cephalalgia; 2014 May; 34(6):464-72. PubMed ID: 24326236
[TBL] [Abstract][Full Text] [Related]
10. Treatment of Persistent Post-Traumatic Headache and Post-Concussion Symptoms Using Repetitive Transcranial Magnetic Stimulation: A Pilot, Double-Blind, Randomized Controlled Trial.
Stilling J; Paxman E; Mercier L; Gan LS; Wang M; Amoozegar F; Dukelow SP; Monchi O; Debert C
J Neurotrauma; 2020 Jan; 37(2):312-323. PubMed ID: 31530227
[TBL] [Abstract][Full Text] [Related]
11. A Randomized Controlled Trial of High Rate rTMS Versus rTMS and Amitriptyline in Chronic Migraine.
Kalita J; Kumar S; Singh VK; Misra UK
Pain Physician; 2021 Sep; 24(6):E733-E741. PubMed ID: 34554691
[TBL] [Abstract][Full Text] [Related]
12. High-frequency repetitive transcranial magnetic stimulation at dorsolateral prefrontal cortex for migraine prevention: A systematic review and meta-analysis.
Mohamad Safiai NI; Mohamad NA; Basri H; Inche Mat LN; Hoo FK; Abdul Rashid AM; Yusof Khan AHK; Loh WC; Baharin J; Fernandez A; Samsudin IN; Mohamed MH; Ching SM; Lee KW; Ramachandran V; Pozo-Rosich P; Wan Sulaiman WA
Cephalalgia; 2022 Sep; 42(10):1071-1085. PubMed ID: 35435045
[TBL] [Abstract][Full Text] [Related]
13. Fremanezumab versus placebo for migraine prevention in patients with documented failure to up to four migraine preventive medication classes (FOCUS): a randomised, double-blind, placebo-controlled, phase 3b trial.
Ferrari MD; Diener HC; Ning X; Galic M; Cohen JM; Yang R; Mueller M; Ahn AH; Schwartz YC; Grozinski-Wolff M; Janka L; Ashina M
Lancet; 2019 Sep; 394(10203):1030-1040. PubMed ID: 31427046
[TBL] [Abstract][Full Text] [Related]
14. Treatment of Executive Function Deficits in autism spectrum disorder with repetitive transcranial magnetic stimulation: A double-blind, sham-controlled, pilot trial.
Ameis SH; Blumberger DM; Croarkin PE; Mabbott DJ; Lai MC; Desarkar P; Szatmari P; Daskalakis ZJ
Brain Stimul; 2020; 13(3):539-547. PubMed ID: 32289673
[TBL] [Abstract][Full Text] [Related]
15. Dramatic placebo effect of high frequency repetitive TMS in treatment of chronic migraine and medication overuse headache.
Granato A; Fantini J; Monti F; Furlanis G; Musho Ilbeh S; Semenic M; Manganotti P
J Clin Neurosci; 2019 Feb; 60():96-100. PubMed ID: 30316627
[TBL] [Abstract][Full Text] [Related]
16. Efficacy and tolerability of erenumab in patients with episodic migraine in whom two-to-four previous preventive treatments were unsuccessful: a randomised, double-blind, placebo-controlled, phase 3b study.
Reuter U; Goadsby PJ; Lanteri-Minet M; Wen S; Hours-Zesiger P; Ferrari MD; Klatt J
Lancet; 2018 Nov; 392(10161):2280-2287. PubMed ID: 30360965
[TBL] [Abstract][Full Text] [Related]
17. Single-pulse transcranial magnetic stimulation for acute treatment of migraine with aura: a randomised, double-blind, parallel-group, sham-controlled trial.
Lipton RB; Dodick DW; Silberstein SD; Saper JR; Aurora SK; Pearlman SH; Fischell RE; Ruppel PL; Goadsby PJ
Lancet Neurol; 2010 Apr; 9(4):373-80. PubMed ID: 20206581
[TBL] [Abstract][Full Text] [Related]
18. A multicenter, prospective, single arm, open label, observational study of sTMS for migraine prevention (ESPOUSE Study).
Starling AJ; Tepper SJ; Marmura MJ; Shamim EA; Robbins MS; Hindiyeh N; Charles AC; Goadsby PJ; Lipton RB; Silberstein SD; Gelfand AA; Chiacchierini RP; Dodick DW
Cephalalgia; 2018 May; 38(6):1038-1048. PubMed ID: 29504483
[TBL] [Abstract][Full Text] [Related]
19. High-rate repetitive transcranial magnetic stimulation in migraine prophylaxis: a randomized, placebo-controlled study.
Misra UK; Kalita J; Bhoi SK
J Neurol; 2013 Nov; 260(11):2793-801. PubMed ID: 23963471
[TBL] [Abstract][Full Text] [Related]
20. Efficacy of single versus three sessions of high rate repetitive transcranial magnetic stimulation in chronic migraine and tension-type headache.
Kalita J; Laskar S; Bhoi SK; Misra UK
J Neurol; 2016 Nov; 263(11):2238-2246. PubMed ID: 27541044
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
